Target type: biologicalprocess
The chemical reactions and pathways resulting in the formation of mineralocorticoids, hormonal C21 corticosteroids synthesized from cholesterol. [ISBN:0198506732]
The mineralocorticoid biosynthetic process is a complex pathway that culminates in the production of aldosterone, a steroid hormone essential for maintaining electrolyte balance and blood pressure. The process begins in the adrenal cortex, specifically in the zona glomerulosa. Here, cholesterol, the precursor molecule, undergoes a series of enzymatic modifications to ultimately yield aldosterone.
The initial steps involve the conversion of cholesterol to pregnenolone through the action of the enzyme cholesterol side-chain cleavage enzyme (CYP11A1). Pregnenolone is then transformed into progesterone by 3 beta-hydroxysteroid dehydrogenase (3beta-HSD). Progesterone is the starting point for the synthesis of both glucocorticoids and mineralocorticoids.
The next step in the mineralocorticoid pathway involves the conversion of progesterone to deoxycorticosterone (DOC) by the enzyme 21-hydroxylase (CYP21A2). DOC is then hydroxylated at the 11-beta position by 11-beta-hydroxylase (CYP11B1) to yield corticosterone.
The crucial step in mineralocorticoid synthesis is the conversion of corticosterone to aldosterone, catalyzed by the enzyme aldosterone synthase (CYP11B2). This enzyme is highly specific for the zona glomerulosa of the adrenal cortex and is responsible for the final steps of aldosterone biosynthesis.
Aldosterone synthase catalyzes two key reactions. First, it hydroxylates corticosterone at the 18 position to produce 18-hydroxycorticosterone. This is followed by a second hydroxylation at the 11 position, resulting in the formation of aldosterone.
The biosynthesis of aldosterone is tightly regulated by a number of factors, including the renin-angiotensin-aldosterone system (RAAS). When blood pressure or blood volume drops, the RAAS is activated, leading to the release of renin from the kidneys. Renin converts angiotensinogen to angiotensin I, which is further cleaved to angiotensin II by angiotensin-converting enzyme (ACE). Angiotensin II acts on the adrenal cortex to stimulate aldosterone production.
Aldosterone, upon release into the bloodstream, exerts its effects on the kidneys, where it promotes sodium reabsorption and potassium excretion. This ultimately leads to increased blood volume and blood pressure, restoring the balance of electrolytes and maintaining normal cardiovascular function.'
"
Protein | Definition | Taxonomy |
---|---|---|
Cytochrome P450 11B2, mitochondrial | A cytochrome P450 11B that is a translation product of the CYP11B2 gene in human. [PRO:DNx, UniProtKB:P19099] | Homo sapiens (human) |
Steroid 21-hydroxylase | A steroid 21-hydroxylase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P08686] | Homo sapiens (human) |
Cytochrome P450 11B2, mitochondrial | A cytochrome P450 11B that is a translation product of the CYP11B2 gene in human. [PRO:DNx, UniProtKB:P19099] | Homo sapiens (human) |
Steroid 21-hydroxylase | A steroid 21-hydroxylase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P08686] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
fluconazole | fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis. Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS. | conazole antifungal drug; difluorobenzene; tertiary alcohol; triazole antifungal drug | environmental contaminant; P450 inhibitor; xenobiotic |
ketoconazole | 1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively. | dichlorobenzene; dioxolane; ether; imidazoles; N-acylpiperazine; N-arylpiperazine | |
letrozole | nitrile; triazoles | antineoplastic agent; EC 1.14.14.14 (aromatase) inhibitor | |
metyrapone | metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency. Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME. | aromatic ketone | antimetabolite; diagnostic agent; EC 1.14.15.4 (steroid 11beta-monooxygenase) inhibitor |
staurosporine | indolocarbazole alkaloid; organic heterooctacyclic compound | apoptosis inducer; bacterial metabolite; EC 2.7.11.13 (protein kinase C) inhibitor; geroprotector | |
fadrozole | Fadrozole: A selective aromatase inhibitor effective in the treatment of estrogen-dependent disease including breast cancer. | imidazopyridine | |
1-benzylimidazole | 1-benzylimidazole: inhibits human thromboxane synthetase | ||
abiraterone | 3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; pyridines | antineoplastic agent; EC 1.14.99.9 (steroid 17alpha-monooxygenase) inhibitor | |
17-(3-pyridyl)androsta-5,16-dien-3-one | 17-(3-pyridyl)androsta-5,16-dien-3-one: a steroidal inhibitor of cytochrome P450(17alpha)/C17-20 lyase; structure given in first source | ||
ketoconazole | (2R,4S)-ketoconazole : A cis-1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine which dioxolane moiety has (2R,4S)-configuration. | cis-1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine | |
posaconazole | aromatic ether; conazole antifungal drug; N-arylpiperazine; organofluorine compound; oxolanes; triazole antifungal drug; triazoles | trypanocidal drug | |
1-(phenylmethyl)benzimidazole | benzimidazoles | ||
etomidate | etomidate : The ethyl ester of 1-[(1R)-1-phenylethyl]-1H-imidazole-5-carboxylic acid. It is an intravenous general anaesthetic with no analgesic activity. Etomidate: Imidazole derivative anesthetic and hypnotic with little effect on blood gases, ventilation, or the cardiovascular system. It has been proposed as an induction anesthetic. | ethyl ester; imidazoles | intravenous anaesthetic; sedative |
1-[(3-methylphenyl)methyl]benzimidazole | benzimidazoles | ||
4-fluoro-N-(3-pyridinyl)benzamide | carbonyl compound; organohalogen compound | ||
4-(1H-imidazol-1-ylmethyl)benzonitrile | benzenes; nitrile | ||
orteronel | orteronel: non-steroidal 17,20-lyase inhibitor; structure in first source | ||
3beta-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene | 3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene: has antineoplastic activity; structure in first source | 3-hydroxy steroid | androgen |
osilodrostat | Osilodrostat: an orally active aldosterone-synthase inhibitor |